Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2015 Apr;67(4):457–466. doi: 10.1002/acr.22483

Figure 1.

Figure 1

Patient selection flow chart

a including hyperlipidemia or lipid lowering agent use or prior diagnosis of myocardial infarction, chronic heart failure, cerebrovascular events, angina, or other forms of chronic heart diseases

b Non-TNF-α-inhibitor biologics include abatacept, rituximab, anakinra, and tocilizumab.